CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Organovo Holdings, Inc.  (ONVO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

ONVO's Revenue Year on Year Growth by Quarter and Year

Organovo Holdings,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
ONVO Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter March 0.81 0.55 0.27 0.12
III Quarter December 1.15 0.33 0.16 0.14
II Quarter September 1.38 0.30 0.05 0.02
I Quarter June 0.89 0.31 0.10 0.11
FY   4.23 1.49 0.58 0.39

Financial Statements
Organovo Holdings,'s forth quarter 2017 Revenue $ 0.81 millions ONVO's Income Statement
Organovo Holdings,'s forth quarter 2016 Revenue $ 0.55 millions Quarterly ONVO's Income Statement
ONVO's Growth by Division See ONVO's Growth by Segment

ONVO Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter March 47.64 % 103.7 % 125 % -65.71 %
III Quarter December 248.48 % 106.25 % 14.29 % -70.21 %
II Quarter September 360 % 500 % 150 % -92.31 %
I Quarter June 187.1 % 210 % -9.09 % -8.33 %
FY   184.03 % 156.9 % 48.72 % -



ONVO Revenue Growth Comment
Organovo Holdings, Inc. reported Revenue rise of 47.64% year on year in the forth quarter, to $ 0.81 millions, this is lower than Organovo Holdings, Inc.'s recent average Revenue surge of 121.18%.

Looking into forth quarter results within Biotechnology & Drugs industry 24 other companies have achieved higher Revenue growth. While Organovo Holdings, Inc.' s Revenue jump of 47.64% ranks overall at the positon no. 496 in the forth quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #25
Healthcare Sector #89
S&P 500 #496
Revenue Y/Y Growth Statistics
High Average Low
502 % 121.18 % -95.1 %
(Sep 30 2015)   (Sep 30 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ONVO's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ONVO's Competitors
Revenue Growth for Organovo Holdings,'s Suppliers
Revenue Growth for ONVO's Customers

You may also want to know
ONVO's Annual Growth Rates ONVO's Profitability Ratios ONVO's Asset Turnover Ratio ONVO's Dividend Growth
ONVO's Roe ONVO's Valuation Ratios ONVO's Financial Strength Ratios ONVO's Dividend Payout Ratio
ONVO's Roa ONVO's Inventory Turnover Ratio ONVO's Growth Rates ONVO's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Nantkwest, Inc.  83.33 %$ 83.333 millions
Psivida Corp.  82.10 %$ 82.099 millions
Cempra, Inc.  81.86 %$ 81.859 millions
Vertex Pharmaceuticals Inc  79.54 %$ 79.541 millions
Ani Pharmaceuticals Inc  78.20 %$ 78.195 millions
Caredx, Inc.  76.53 %$ 76.532 millions
Vivus Inc  76.27 %$ 76.273 millions
Anavex Life Sciences Corp.  73.19 %$ 73.195 millions
Keryx Biopharmaceuticals Inc  73.17 %$ 73.172 millions
Cytosorbents Corp  72.00 %$ 72.000 millions
Corcept Therapeutics Inc  71.84 %$ 71.839 millions
Advanced Medical Isotope Corp  69.07 %$ 69.068 millions
Innoviva, Inc.  67.49 %$ 67.488 millions
Presbia Plc  66.67 %$ 66.667 millions
Intelgenx Technologies Corp.  65.40 %$ 65.403 millions
Omeros Corp  65.21 %$ 65.211 millions
Gtx Corp  64.91 %$ 64.912 millions
Nevro Corp  64.32 %$ 64.315 millions
Dimension Therapeutics, Inc.  64.01 %$ 64.007 millions
U.s. Stem Cell, Inc.  62.46 %$ 62.458 millions
Teladoc, Inc.  59.54 %$ 59.543 millions
Htg Molecular Diagnostics, Inc  58.47 %$ 58.474 millions
Myokardia Inc  58.45 %$ 58.451 millions
Quintiles Ims Holdings, Inc.  55.83 %$ 55.830 millions
Glaukos Corp  55.50 %$ 55.495 millions
Five Prime Therapeutics Inc  55.44 %$ 55.445 millions
Albany Molecular Research Inc  55.17 %$ 55.165 millions
Psychemedics Corp  53.13 %$ 53.126 millions
Axogen, Inc.  50.91 %$ 50.905 millions
Organovo Holdings, Inc.  48.18 %$ 48.175 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com